Beijing Historical Income Statement

300858 Stock   16.47  0.25  1.54%   
Historical analysis of Beijing Scitop income statement accounts such as Net Interest Income of 24.6 M, Interest Expense of 266.8 K or Selling General Administrative of 27.9 M can show how well Beijing Scitop Bio performed in making a profits. Evaluating Beijing Scitop income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Beijing Scitop's future profits or losses.
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Beijing Scitop Bio latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Beijing Scitop Bio is a good buy for the upcoming year.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Beijing Scitop Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

About Beijing Income Statement Analysis

Beijing Scitop Bio Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Beijing Scitop shareholders. The income statement also shows Beijing investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Beijing Scitop Income Statement Chart

At present, Beijing Scitop's Tax Provision is projected to decrease significantly based on the last few years of reporting. The current year's Net Interest Income is expected to grow to about 24.6 M, whereas Interest Expense is forecasted to decline to about 266.8 K.

Tax Provision

The amount set aside by a company to cover any estimated taxes for the current period. It reflects the company's expected tax liabilities.

Total Revenue

Total revenue comprises all receipts Beijing Scitop Bio generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of Beijing Scitop Bio minus its cost of goods sold. It is profit before Beijing Scitop operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.
Most accounts from Beijing Scitop's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Beijing Scitop Bio current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Beijing Scitop Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
At present, Beijing Scitop's Tax Provision is projected to decrease significantly based on the last few years of reporting. The current year's Net Interest Income is expected to grow to about 24.6 M, whereas Interest Expense is forecasted to decline to about 266.8 K.
 2021 2022 2023 2024 (projected)
Gross Profit183.5M191.9M163.3M174.1M
Total Revenue364.6M369.2M299.2M349.6M

Beijing Scitop income statement Correlations

-0.52-0.380.280.180.150.450.270.14-0.290.43-0.330.310.270.05-0.28-0.63-0.23-0.29
-0.52-0.520.560.640.690.490.610.680.820.320.160.590.610.75-0.620.990.810.76
-0.38-0.52-0.76-0.8-0.95-0.97-0.93-0.93-0.62-0.580.4-0.94-0.93-0.880.98-0.38-0.63-0.47
0.280.56-0.760.980.820.890.920.810.730.910.270.920.920.63-0.850.450.790.74
0.180.64-0.80.980.890.90.960.90.830.80.180.960.960.74-0.90.530.880.82
0.150.69-0.950.820.890.930.970.970.810.57-0.220.960.970.89-0.980.560.810.67
0.450.49-0.970.890.90.930.970.930.640.74-0.210.980.970.81-0.970.340.690.56
0.270.61-0.930.920.960.970.970.960.80.72-0.081.01.00.84-0.980.480.830.72
0.140.68-0.930.810.90.970.930.960.840.55-0.210.960.960.92-0.970.560.860.74
-0.290.82-0.620.730.830.810.640.80.840.440.20.780.80.73-0.760.760.980.94
0.430.32-0.580.910.80.570.740.720.550.440.390.740.720.35-0.640.220.50.5
-0.330.160.40.270.18-0.22-0.21-0.08-0.210.20.39-0.09-0.08-0.360.230.230.230.41
0.310.59-0.940.920.960.960.981.00.960.780.74-0.091.00.83-0.980.460.810.7
0.270.61-0.930.920.960.970.971.00.960.80.72-0.081.00.84-0.980.480.830.72
0.050.75-0.880.630.740.890.810.840.920.730.35-0.360.830.84-0.890.650.750.61
-0.28-0.620.98-0.85-0.9-0.98-0.97-0.98-0.97-0.76-0.640.23-0.98-0.98-0.89-0.49-0.76-0.64
-0.630.99-0.380.450.530.560.340.480.560.760.220.230.460.480.65-0.490.750.72
-0.230.81-0.630.790.880.810.690.830.860.980.50.230.810.830.75-0.760.750.96
-0.290.76-0.470.740.820.670.560.720.740.940.50.410.70.720.61-0.640.720.96
Click cells to compare fundamentals

Beijing Scitop Account Relationship Matchups

Beijing Scitop income statement Accounts

201920202021202220232024 (projected)
Tax Provision17.3M16.6M14.6M15.8M8.6M11.7M
Net Interest Income(224.4K)3.5M6.3M3.2M23.5M24.6M
Interest Expense337.5K66.3K439.1K405.3K500.9K266.8K
Selling General Administrative21.1M24.4M40.8M34.9M36.5M27.9M
Total Revenue308.1M339.2M364.6M369.2M299.2M349.6M
Gross Profit157.5M163.9M183.5M191.9M163.3M174.1M
Other Operating Expenses3.0M2.9M3.1M2.9M3.3M3.1M
Operating Income108.7M110.4M94.4M115.8M73.5M99.4M
Net Income From Continuing Ops93.3M96.6M109.5M109.9M93.5M93.1M
Ebit101.0M103.4M89.6M115.8M133.2M97.5M
Research Development14.8M17.6M27.2M22.1M34.2M21.1M
Cost Of Revenue150.6M175.3M181.2M177.3M135.9M175.5M
Total Operating Expenses199.4M228.7M270.2M253.4M225.7M250.2M
Income Before Tax110.6M113.2M124.2M125.7M102.0M109.3M
Net Income Applicable To Common Shares93.3M96.6M109.5M109.9M126.4M91.8M
Net Income93.3M96.6M109.5M109.9M93.5M93.2M
Income Tax Expense17.3M16.6M14.6M15.8M18.1M17.1M
Interest Income156.9K3.5M6.7M3.6M24.0M25.2M
Ebitda116.1M123.0M140.7M144.1M165.7M133.3M
Reconciled Depreciation5.2M9.8M16.1M18.0M20.3M12.3M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Beijing Stock

Beijing Scitop Bio Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Beijing Scitop shareholders. The income statement also shows Beijing investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).